| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |